Prevalence of Asymptomatic Carotid Stenosis in Korea Based on Health Screening Population by Roh, Young-Nam et al.
© 2011 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
pISSN 1011-8934
eISSN 1598-6357
Prevalence of Asymptomatic Carotid Stenosis in Korea Based  
on Health Screening Population
We attempted to investigate the prevalence and risk factors of carotid artery stenosis in 
Korea. Twenty thousand seven hundred twelve individuals who underwent carotid artery 
ultrasonography for health screening between March 2005 and March 2010 were 
retrospectively evaluated. The population was divided into four groups, according to the 
degree of stenosis, as Group A, below 29%; Group B, 30% to 49%; Group C, 50% to 
74%; Group D, above 75%. The medical records of the individuals were investigated, and 
Fisher’s exact test, chi-square tests, Kruskal-Wallis tests and a binary logistic regression 
model were used for statistical analysis. The prevalence of carotid stenosis was Group B, 
5.5%; Group C, 0.9%; Group D, 0.1%. Old age, male gender, hypertension, diabetes 
mellitus and ischemic heart disease were significantly higher in Groups C and D (P = 0.001, 
0.001, 0.001, 0.048, and 0.001, respectively). Among the males aged over 65 yr, the 
prevalence of carotid stenosis ≥ 50% and ≥ 30% were 4.0% and 18.2%, respectively. 
Asymptomatic carotid stenosis is not uncommon in Korea. Carotid ultrasonography is 
necessary for people with above-listed risk factors.
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Internal carotid artery (ICA) atherosclerotic stenosis is responsi-
ble for a significant proportion of transient ischemic attacks (TIA) 
and approximately 30% of ischemic strokes (1). Population-based 
epidemiological studies using ultrasound have shown that the 
prevalence of asymptomatic carotid artery stenosis (CAS) ≥ 50% 
varies between 4% and 8% in adults (2). The annual risk of ipsi-
lateral neurologic deficits for asymptomatic CAS was published 
in several studies (2-8). 
  The screening of individuals with asymptomatic significant 
CAS is important to find the patients who need serial surveil-
lance, medication, intervention or surgery. In Korea, however, 
the prevalence of CAS in the asymptomatic people has not been 
reported. The role of screening depends on the incidence of the 
disease in the population, and the subpopulation in which the 
screening has a cost-effective benefit must be identified.   
  In this study, we attempted to investigate the prevalence of 
asymptomatic CAS in Korea, and we wanted to identify the risk 
factors of CAS. We investigated the prevalence of CAS accord-
ing to the subpopulation with a combination of risk factors. 
MATERIALS AND METHODS
Twenty thousand seven hundred twelve neurologically asymp-
tomatic people underwent carotid artery duplex ultrasound for 
health screening between March 2005 and March 2010. We ex-
cluded the individuals with history of cerebrovascular accident 
or symptoms indicating TIA. The individuals’ characteristics and 
degrees of CAS were retrospectively evaluated. The population 
was divided into four groups according to the degree of CAS with 
using real-time B-mode high resolution ultrasonography as group 
A, below 29% of CAS; Group B, 30% to 49% of CAS; Group C, 50% 
to 74% of CAS; Group D, above 75% of CAS. The medical records 
of all the individuals were investigated.
  Duplex ultrasound was performed by radiologists or registered 
vascular technologists. And the carotid artery diameter was mea-
sured on a longitudinal and transverse view of the proximal ICA 
and carotid bifurcation on both sides. The intima-media thick-
ness (IMT), the rate of diameter reduction and the peak systolic 
velocity in the internal carotid artery (just distal to the carotid 
bifurcation) were measured. The degrees of CAS were measured 
by the rate of diameter reduction according to the European Ca-
rotid Surgery Trial (ECST) method. Ultrasonography scanner 
equipped with 9-to-4-MHz linear-array transducer and a 5-MHz 
pulsed Doppler (SIEMENS, Antares, Germany) or a 10-MHz lin-
ear-array transducer and a 4.4-MHz pulsed Doppler (GE, LOGIQ 
9, Waukesha, WI, USA) were used for duplex ultrasound. 
  To identify the risk factors of CAS, univariate analysis with Fish-
er’s exact test, chi-square tests, Kruskal-Wallis tests and multi-
variate analysis with a binary logistic regression model was con-
ducted using the individuals’ demographics (age, gender) and Roh Y-N, et al.  •  Prevalence of Asymptomatic Carotid Stenosis
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the clinical variables (hypertension, diabetes mellitus, ischemic 
heart disease, total cholesterol, HDL-cholesterol, LDL-choles-
terol, HbA-1c). A total of 8,622 (41.6%) people did not provide 
information about their exact current status of smoking, so the 
history of smoking was excluded from the risk factor analysis. 
According to the subgroups with a combination of risk factors, 
we calculated the prevalence of CAS.
Ethics statement
This study was reviewed and approved by the institutional re-
view board of the Samsung Medical Center (No. 2011-03-005). 
The board exempted informed consent because it was a retro-
spective study.
RESULTS
Table 1 demonstrates demographic and clinical characteristics 
of the study population. The mean age of the population was 
55.1 yr (range: 18 to 91 yr) and 83% were male. The prevalence 
of CAS according to the degree of stenosis is shown in Table 2. 
The prevalence of CAS was 5.5% in Group B, 0.9% in Group C 
and 0.1% in Group D. The prevalence of CAS over 50% was 1% 
among the entire study population.
  On univariate analysis (Table 3), CAS was more common in 
people aged over 65 yr (P < 0.001), males (P < 0.001), people with 
hypertension (P < 0,001), people with diabetes mellitus (P < 0.001) 
and people with ischemic heart disease (P < 0.001). The total 
cholesterol (P = 0.003) and LDL-cholesterol (P = 0.042) levels 
were higher in the people with CAS, and the HDL-cholesterol 
(P = 0.001) level was lower in the people with CAS. 
  On multivariate analysis (Table 4), the risk factors for CAS more 
than 50% were old age (OR, 1.11; 95% CI, 1.10-1.13), male gen-
der (OR, 3.46; 95% CI, 2.12-5.66), hypertension (OR, 1.69; 95% 
CI, 1.25-2.28), diabetes mellitus (OR, 1.41; 95% CI, 1.00-1.99) and 
ischemic heart disease (OR, 1.93; 95% CI, 1.29-2.87).  
  Table 5 demonstrates the prevalence of CAS ≥ 50% according 
to the subpopulations with a combination of the risk factors. The 
prevalence of CAS ≥ 50% was 3.1% among the people aged over 
65 yr, and it was 4.0% among males aged over 65 yr. It was 4.8% 
among males aged over 65 yr with hypertension, and it was 6.7% 
among males aged over 65 yr with hypertension and diabetes 
mellitus. It was 5.6% among males aged over 65 yr with hyper-
tension, diabetes mellitus and ischemic heart disease. The prev-
alence of CAS ≥ 30% was 14.8%, 18.2%, 22.8%, 26.9% and 30.6% 
in each of the above subgroups, respectively.
DISCUSSION
The contribution of CAS to the overall stroke burden is difficult 
Table 3. Univariate analysis for the risk factors of carotid artery stenosis
Variables Group A (< 30%) Group B (30%-49%) Group C (50%-74%) Group D (75% ≤) P value
Age (yr)   54   61   65   62 < 0.001*
Male (%) 15,984 (82.5) 1,015 (88.8)    167 (91.8) 16 (88.2) < 0.001
†
Hypertension (%)   5,579 (28.9)    590 (51.6) 102 (56) 10 (52.6) < 0.001
‡
Diabetes mellitus (%)   2,139 (11.0)    257 (22.5)      44 (24.2)   4 (21.1) < 0.001
†
Ischemic heart disease (%)    911 (4.7)    163 (14.3)      27 (14.8)   5 (26.3) < 0.001
†
TC (mg/dL) 192 188 184 188  0.003*
LDL-C (mg/dL) 125 124 117 124  0.042*
HDL-C (mg/dL)   51   49   49   50  0.001*
*Kruskal-Wallis; 
†Fisher’s exact; 
‡Chi-square. TC, total cholesterol; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol. 
Table 1. The characteristics of the 20,712 study population
Characteristics Findings 
Mean age (yr) (range) 55.1 ± 9.0 (18-91)
Gender, male (%) 17,182 (83)
Hypertension (%)      6,281 (30.3)
Diabetes mellitus (%)      2,444 (11.8)
Cholesterolemia (%)      5,513 (26.6)
Ischemic heart disease (%)     1,106 (5.3)
Body mass index (BMI) (kg/m
2)    24.4 ± 2.6 
Fasting blood sugar (FBS) (mg/dL)     97.4 ± 20.8 
Total cholesterol (mg/dL)   193.7 ± 33.0 
LDL-cholesterol (mg/dL)   128.6 ± 29.8 
HDL-cholesterol (mg/dL)     53.6 ± 13.3 
HbA1c (%)       5.6 ± 0.75
Table 2. The prevalence of carotid artery stenosis
Degree of stenosis    No. (%)
Stenosis less than 50%
   Group A (< 30%)
   Group B (30%-49%)
 20,511 (99)
    19,368 (93.5)
    1,143 (5.5)
Stenosis more than 50%
   Group C (50%-74%)
   Group D (≥ 75%)
    201 (1)
       182 (0.9)
         19 (0.1)
Table 4. Multivariate analysis with binary logistic regression model for the risk factors 
of carotid artery stenosis (Stenosis < 50% vs 50% ≤ Stenosis)
Risk factors of carotid stenosis P value HR (95% C.I.)
Age > 65 yr old 0.001 1.11 (1.10-1.13)
Male 0.001 3.46 (2.12-5.66)
Hypertension 0.001 1.69 (1.25-2.28)
Diabetes mellitus 0.048 1.41 (1.00-1.99)
Ischemic heart disease 0.001 1.93 (1.29-2.87)
LDL-cholesterol 0.806 1.00 (1.00-1.00)
Cholesterolemia 0.156 1.25 (0.92-1.71)Roh Y-N, et al.  •  Prevalence of Asymptomatic Carotid Stenosis
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to approximate. Eighty-eight percent of strokes are ischemic, 
and 20% or fewer of these are due to large-artery stenosis (9-15). 
A subgroup of these has CAS, and CAS can be approached with 
endarterectomy or stenting. The screening of asymptomatic CAS 
followed by the best medical therapy or an invasive procedure is 
expected to reduce the risk of TIA and stroke in the general pop-
ulation. 
  The presence of CAS predisposes people to TIA and stroke, 
and the risk is correlated with the severity of CAS. For the peo-
ple with 0 to 29% stenosis, TIA or stroke occurred in 2.1% each 
year. For the people with 30% to 74% stenosis, TIA or stroke oc-
curred in 5.7%, and for the people with 75% to 100% stenosis, 
TIA or stroke occurred in 19.5% (16). O’Holleran reported that 
the 60% of the people with more than 75% stenosis had a stroke 
or TIA during 5 yr of follow-up (17). The reported risk of TIA or 
stroke in the people with asymptomatic CAS has varied, and the 
stroke risk depends on more than just the degree of carotid artery 
narrowing. Most studies consider stenosis of 50% or greater, or 
60% or greater to be clinically important. In the randomized tri-
als that have evaluated the role of carotid endarterectomy (CEA) 
in asymptomatic patients, the 5-yr risk of stroke in the individu-
als with CAS more than 60% was 11.0%-11.8% without perform-
ing CEA (18, 19).
  Several population-based cohort and cross-sectional studies 
have examined the prevalence of CAS. The estimates of the prev-
alence of CAS from population-based studies have ranged from 
0.5% to 8% (2, 11, 20-22). The prevalence of clinically important 
CAS (60% to 99%) is estimated to be about 1% in people aged 
over 65 yr (23). In our study, the prevalence of CAS more than 
50% was 1% in the overall population. But with the combination 
of the risk factors, the prevalence was increased (Table 5). Espe-
cially in the male population aged over 65 yr, the prevalence of 
CAS more than 50% was 4%. The clinical importance of our study 
is that it is one of the first reports that have defined the prevalence 
of CAS in Korea based on a large population. 
  The CAS more than 50% is regarded as the indication for in-
tervention or surgery if it is accompanied by neurologic signs or 
symptoms or it shows an unfavorable morphology. If the degree 
of stenosis is less than 50%, then serial surveillance and medica-
tion are needed. As seen in the Table 5, the population who need 
serial surveillance and medication is high according to the com-
bination of risk factors. 
  Medical therapy is recommended for the asymptomatic peo-
ple with CAS less than 60%. Medical therapy can favorably alter 
the natural history of asymptomatic carotid disease. The role of 
aspirin or other antiplatelet agents in patients with asymptom-
atic carotid lesions has been established in several trials. The cut-
off value of CAS that needs medical therapy has not been de-
fined. But the high prevalence of CAS more than 30% was re-
ported in our study, especially in the old male population. For 
example, in males aged over 65 yr, the incidence of CAS more 
than 30% was 18.2%. Medical therapy for these individuals with 
mild CAS can be expected to reduce the risk of cardiovascular 
events. 
  One of the purposes of carotid screening with duplex ultra-
sound is to find the population who are the potential candidates 
for surgical intervention. But the actual benefit of carotid screen-
ing followed by surgical intervention for the proper candidate 
has not been defined. Based on the results of our study, we cal-
culated the benefit of carotid screening for the male population 
aged over 65 yr from the point of view of stroke prevention. The 
prevalence of CAS more than 50% was 4% in the males aged over 
65 yr. In the 2004 Asymptomatic Carotid Surgery Trial (ACST), 
the 5-yr risk of stroke in the patients with CAS more than 60% 
was 11.8% without CEA. The relative risk reduction of CEA was 
46% (19). From the data of the ACST, we regarded the 5-yr risk 
of stroke in the population with CAS more than 50% as roughly 
10%, and the relative risk reduction of CEA as roughly 50%. With 
these suppositions, among the 1,000 males aged over 65 yr, carot-
id screening with duplex ultrasound can detect 40 patients with 
CAS more than 50%. Among them, 4 patients are potential vic-
tims of stroke within 5 yr. If CEA is performed in the proper can-
Table 5. The incidence of carotid artery stenosis according to the subgroups 
Subgroups Group A (< 30%) Group B (30%-49%) Group C (50%-74%) Group D (75% ≤) Total 
Overall 











Age > 65 yr old
   No. (%)
 
  2,771 (85.1)
 
     384 (11.7)
 
  95 (2.9)
 
  6 (0.2)
 
  3,256 (100)
Age > 65 yr old, male
   No. (%)
 
  1,838 (81.8)
 
     320 (14.2)
 
  86 (3.8)
 
  4 (0.2)
 
  2,248 (100)
Age > 65 yr old, male with hypertension
   No. (%)
 
     817 (77.1)
 
     191 (18.0)
 




  1,059 (100)
Age > 65 yr old, male with hypertension 
   and diabetes mellitus
   No. (%)
 
     206 (73.0)
 
       57 (20.2)
 




     282 (100)
Age > 65 yr old, male with hypertension, 
   diabetes mellitus and ischemic heart disease
   No. (%)
 
       25 (69.4)
 
      9 (25)
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didates, then stroke can be prevented in 2 patients. Although this 
is not direct evidence of benefit of carotid screening with duplex 
ultrasound, it can be expected that carotid screening followed 
by CEA for the proper candidates can prevent at least 1 stroke 
per 1000 male population aged over 65 yr. There still is not direct 
evidence that screening adults with duplex ultrasound for as-
ymptomatic CAS reduces fatal or nonfatal stroke (23). The actu-
al benefit of carotid screening with duplex ultrasound and the 
cost-effectiveness must be defined in further studies. 
  This study was performed on the subjects who visited a tertia-
ry medical center for routine health screening. So the subjects of 
this study may not be the real representatives of general Korean 
population. The study population may be biased by regional 
characteristics or socio-economic status. This is the limitation 
of this study.
  In conclusion, asymptomatic CAS is not uncommon in Kore-
ans. Carotid duplex ultrasound is necessary for people with risk 
factors such as male gender, old age, hypertension, diabetes and 
ischemic heart disease. 
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Prevalence of Asymptomatic Carotid Stenosis in Korea Based on Health Screening 
Population
Young-Nam Roh, Shin-Young Woo, Nari Kim, Seonwoo Kim, Young-Wook Kim and Dong-Ik Kim
Carotid artery (CA) stenosis is responsible for a significant proportion of ischemic attacks in brain. In Korea, however, the 
prevalence of CA stenosis in the asymptomatic people has not been reported. We analyzed the health screening records of CA 
ultrasonography (20,712 cases) and found that the prevalence of CA stenosis > 50% was 1%. Old age, male gender, hypertension, 
diabetes mellitus and ischemic heart disease were significantly higher in CA stenosis group.